PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
zeb1b
|
ENSDARG00000013207 | zinc finger E-box binding homeobox 1b |
zeb1a
|
ENSDARG00000016788 | zinc finger E-box binding homeobox 1a |
zeb1b
|
ENSDARG00000113922 | zinc finger E-box binding homeobox 1b |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
zeb1b | dr11_v1_chr12_-_26851726_26851726 | -0.61 | 6.6e-11 | Click! |
zeb1a | dr11_v1_chr2_-_43851915_43851915 | -0.53 | 3.7e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_20239141 | 144.31 |
ENSDART00000101152
ENSDART00000152473 |
spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr19_-_48312109 | 89.61 |
ENSDART00000161103
|
si:ch73-359m17.9
|
si:ch73-359m17.9 |
chr10_-_2942900 | 79.51 |
ENSDART00000002622
|
oclna
|
occludin a |
chr22_+_661711 | 79.39 |
ENSDART00000113795
|
elf3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr21_-_25741411 | 77.48 |
ENSDART00000101211
|
cldnh
|
claudin h |
chr21_-_38153824 | 72.18 |
ENSDART00000151226
|
klf5l
|
Kruppel-like factor 5 like |
chr19_-_30404096 | 71.92 |
ENSDART00000103475
|
agr2
|
anterior gradient 2 |
chr2_+_68789 | 70.21 |
ENSDART00000058569
|
cldn1
|
claudin 1 |
chr1_-_50247 | 69.89 |
ENSDART00000168428
|
ildr1a
|
immunoglobulin-like domain containing receptor 1a |
chr16_+_17715243 | 68.39 |
ENSDART00000149437
ENSDART00000149596 |
si:dkey-87o1.2
|
si:dkey-87o1.2 |
chr6_-_7776612 | 66.63 |
ENSDART00000190269
|
myh9a
|
myosin, heavy chain 9a, non-muscle |
chr8_-_18667693 | 65.39 |
ENSDART00000100516
|
stap2b
|
signal transducing adaptor family member 2b |
chr21_+_30351256 | 65.01 |
ENSDART00000078341
|
foxi3a
|
forkhead box I3a |
chr22_+_661505 | 63.16 |
ENSDART00000149460
|
elf3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr25_-_22187397 | 59.74 |
ENSDART00000123211
ENSDART00000139110 |
pkp3a
|
plakophilin 3a |
chr7_-_53117131 | 57.34 |
ENSDART00000169211
ENSDART00000168890 ENSDART00000172179 ENSDART00000167882 |
cdh1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr2_-_722156 | 56.62 |
ENSDART00000045770
ENSDART00000169498 |
foxq1a
|
forkhead box Q1a |
chr15_-_33964897 | 56.17 |
ENSDART00000172075
ENSDART00000158126 ENSDART00000160456 |
lsr
|
lipolysis stimulated lipoprotein receptor |
chr12_-_4243268 | 54.81 |
ENSDART00000131275
|
zgc:92313
|
zgc:92313 |
chr22_+_1170294 | 52.26 |
ENSDART00000159761
ENSDART00000169809 |
irf6
|
interferon regulatory factor 6 |
chr16_+_28792158 | 52.20 |
ENSDART00000161525
ENSDART00000027417 |
zgc:171704
|
zgc:171704 |
chr9_+_48007081 | 50.67 |
ENSDART00000060593
ENSDART00000099835 |
zgc:92380
|
zgc:92380 |
chr13_+_33606739 | 49.98 |
ENSDART00000026464
|
cfl1l
|
cofilin 1 (non-muscle), like |
chr16_-_23346095 | 49.77 |
ENSDART00000160546
|
si:dkey-247k7.2
|
si:dkey-247k7.2 |
chr1_-_45177373 | 48.55 |
ENSDART00000143142
ENSDART00000034549 |
zgc:111983
|
zgc:111983 |
chr1_+_56180416 | 48.21 |
ENSDART00000089358
|
crb3b
|
crumbs homolog 3b |
chr18_-_7539166 | 48.03 |
ENSDART00000133541
|
si:dkey-30c15.2
|
si:dkey-30c15.2 |
chr22_-_15578402 | 45.69 |
ENSDART00000062986
|
hsh2d
|
hematopoietic SH2 domain containing |
chr5_-_65021736 | 44.78 |
ENSDART00000162368
ENSDART00000161876 |
anxa1c
|
annexin A1c |
chr22_-_17677947 | 44.39 |
ENSDART00000139911
|
tjp3
|
tight junction protein 3 |
chr5_-_37959874 | 44.07 |
ENSDART00000031719
|
mpzl2b
|
myelin protein zero-like 2b |
chr19_+_791538 | 43.74 |
ENSDART00000146554
ENSDART00000138406 |
tmem79a
|
transmembrane protein 79a |
chr16_-_26676685 | 42.63 |
ENSDART00000103431
|
esrp1
|
epithelial splicing regulatory protein 1 |
chr25_+_22107643 | 42.47 |
ENSDART00000089680
|
sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr14_-_33277743 | 42.30 |
ENSDART00000048130
|
stard14
|
START domain containing 14 |
chr19_-_30403922 | 41.26 |
ENSDART00000181841
|
agr2
|
anterior gradient 2 |
chr16_+_28754403 | 40.98 |
ENSDART00000103340
|
s100v1
|
S100 calcium binding protein V1 |
chr21_-_25741096 | 40.57 |
ENSDART00000181756
|
cldnh
|
claudin h |
chr15_+_36096689 | 40.24 |
ENSDART00000049849
|
col4a3
|
collagen, type IV, alpha 3 |
chr13_-_21672131 | 40.24 |
ENSDART00000067537
|
elovl6l
|
ELOVL family member 6, elongation of long chain fatty acids like |
chr22_+_11756040 | 39.79 |
ENSDART00000105808
|
krt97
|
keratin 97 |
chr3_+_49021079 | 39.69 |
ENSDART00000162012
|
zgc:163083
|
zgc:163083 |
chr12_-_46228023 | 39.60 |
ENSDART00000153455
|
si:ch211-226h7.6
|
si:ch211-226h7.6 |
chr21_-_7928101 | 39.45 |
ENSDART00000151543
ENSDART00000114982 |
f2rl1.2
|
coagulation factor II (thrombin) receptor-like 1, tandem duplicate 2 |
chr7_+_22680560 | 38.93 |
ENSDART00000133761
|
ponzr4
|
plac8 onzin related protein 4 |
chr12_-_11349899 | 38.25 |
ENSDART00000079645
|
zgc:174164
|
zgc:174164 |
chr6_+_103361 | 37.56 |
ENSDART00000151899
|
ldlrb
|
low density lipoprotein receptor b |
chr17_+_24843401 | 37.47 |
ENSDART00000110179
|
cx34.4
|
connexin 34.4 |
chr23_-_41651759 | 37.09 |
ENSDART00000146808
|
si:ch73-184c24.1
|
si:ch73-184c24.1 |
chr17_-_30652738 | 37.07 |
ENSDART00000154960
|
sh3yl1
|
SH3 and SYLF domain containing 1 |
chr3_-_61162750 | 36.34 |
ENSDART00000055064
|
pvalb8
|
parvalbumin 8 |
chr11_+_10984293 | 35.66 |
ENSDART00000065933
|
itgb6
|
integrin, beta 6 |
chr7_+_14291323 | 35.61 |
ENSDART00000053521
|
rhcga
|
Rh family, C glycoprotein a |
chr7_+_32901658 | 35.59 |
ENSDART00000115420
|
ano9b
|
anoctamin 9b |
chr1_+_26411496 | 35.53 |
ENSDART00000112263
|
arhgef38
|
Rho guanine nucleotide exchange factor (GEF) 38 |
chr14_-_33278084 | 35.16 |
ENSDART00000132850
|
stard14
|
START domain containing 14 |
chr5_-_37900350 | 34.96 |
ENSDART00000084839
ENSDART00000084841 ENSDART00000133437 |
tmprss13b
|
transmembrane protease, serine 13b |
chr21_-_7940043 | 34.55 |
ENSDART00000099733
ENSDART00000136671 |
f2rl1.1
|
coagulation factor II (thrombin) receptor-like 1, tandem duplicate 1 |
chr10_+_17776981 | 34.48 |
ENSDART00000141693
|
ccl19b
|
chemokine (C-C motif) ligand 19b |
chr17_+_2549503 | 34.48 |
ENSDART00000156843
|
si:dkey-248g15.3
|
si:dkey-248g15.3 |
chr1_+_55002583 | 33.83 |
ENSDART00000037250
|
si:ch211-196h16.12
|
si:ch211-196h16.12 |
chr16_-_20312146 | 33.15 |
ENSDART00000134980
|
si:dkeyp-86h10.3
|
si:dkeyp-86h10.3 |
chr16_+_17714664 | 33.00 |
ENSDART00000149042
|
si:dkey-87o1.2
|
si:dkey-87o1.2 |
chr19_-_48010490 | 32.65 |
ENSDART00000159938
|
FBXL19
|
zgc:158376 |
chr14_+_48862987 | 32.42 |
ENSDART00000167810
|
zgc:154054
|
zgc:154054 |
chr19_-_40198478 | 31.99 |
ENSDART00000191736
|
grn2
|
granulin 2 |
chr20_-_3238110 | 31.84 |
ENSDART00000008077
|
spint1b
|
serine peptidase inhibitor, Kunitz type 1 b |
chr19_-_10771558 | 31.48 |
ENSDART00000085165
|
slc9a3.2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3, tandem duplicate 2 |
chr16_-_25233515 | 31.33 |
ENSDART00000058943
|
zgc:110182
|
zgc:110182 |
chr17_-_32426392 | 30.97 |
ENSDART00000148455
ENSDART00000149885 ENSDART00000179314 |
grhl1
|
grainyhead-like transcription factor 1 |
chr16_-_45235947 | 30.81 |
ENSDART00000164436
|
si:dkey-33i11.4
|
si:dkey-33i11.4 |
chr1_+_1789357 | 30.66 |
ENSDART00000006449
|
atp1a1a.2
|
ATPase Na+/K+ transporting subunit alpha 1a, tandem duplicate 2 |
chr5_+_26212621 | 30.58 |
ENSDART00000134432
|
oclnb
|
occludin b |
chr19_+_7567763 | 30.46 |
ENSDART00000140411
|
s100a11
|
S100 calcium binding protein A11 |
chr14_+_3495542 | 30.04 |
ENSDART00000168934
|
gstp2
|
glutathione S-transferase pi 2 |
chr5_+_57658898 | 29.68 |
ENSDART00000074268
ENSDART00000124568 |
zgc:153929
|
zgc:153929 |
chr12_-_46252062 | 29.46 |
ENSDART00000153223
|
si:ch211-226h7.5
|
si:ch211-226h7.5 |
chr8_-_38022298 | 29.41 |
ENSDART00000067809
|
rab11fip1a
|
RAB11 family interacting protein 1 (class I) a |
chr3_+_21189766 | 29.32 |
ENSDART00000078807
|
zgc:123295
|
zgc:123295 |
chr19_-_5332784 | 29.14 |
ENSDART00000010373
|
krt1-19d
|
keratin, type 1, gene 19d |
chr11_+_11504014 | 29.11 |
ENSDART00000104264
ENSDART00000134806 ENSDART00000132291 |
zgc:171226
|
zgc:171226 |
chr24_+_26006730 | 29.06 |
ENSDART00000140384
ENSDART00000139184 |
ccl20b
|
chemokine (C-C motif) ligand 20b |
chr10_-_35149513 | 28.88 |
ENSDART00000063434
ENSDART00000131291 |
ripk4
|
receptor-interacting serine-threonine kinase 4 |
chr22_+_3914318 | 28.79 |
ENSDART00000188774
ENSDART00000082034 |
FO904903.1
|
Danio rerio major histocompatibility complex class I ULA (mhc1ula), mRNA. |
chr9_+_7358749 | 28.64 |
ENSDART00000081660
|
ihha
|
Indian hedgehog homolog a |
chr5_-_30615901 | 28.63 |
ENSDART00000147769
|
si:ch211-117m20.5
|
si:ch211-117m20.5 |
chr3_-_19561058 | 28.44 |
ENSDART00000079323
|
zgc:163079
|
zgc:163079 |
chr17_+_26965351 | 28.24 |
ENSDART00000114215
ENSDART00000147192 |
grhl3
|
grainyhead-like transcription factor 3 |
chr24_-_8831866 | 28.24 |
ENSDART00000066780
ENSDART00000143501 |
gcm2
|
glial cells missing homolog 2 (Drosophila) |
chr1_+_54865552 | 27.73 |
ENSDART00000145381
|
si:ch211-196h16.5
|
si:ch211-196h16.5 |
chr20_-_42702832 | 27.50 |
ENSDART00000134689
ENSDART00000045816 |
plg
|
plasminogen |
chr11_+_37216668 | 27.41 |
ENSDART00000173076
|
zgc:112265
|
zgc:112265 |
chr7_-_34265481 | 27.38 |
ENSDART00000173596
|
si:ch211-98n17.5
|
si:ch211-98n17.5 |
chr13_+_24750078 | 26.79 |
ENSDART00000021053
|
col17a1b
|
collagen, type XVII, alpha 1b |
chr25_+_10416583 | 26.73 |
ENSDART00000073907
|
ehf
|
ets homologous factor |
chr16_+_23960933 | 26.40 |
ENSDART00000146077
|
apoeb
|
apolipoprotein Eb |
chr1_+_1838164 | 26.25 |
ENSDART00000006013
|
atp1a1a.5
|
ATPase Na+/K+ transporting subunit alpha 1a, tandem duplicate 5 |
chr18_-_46354269 | 26.15 |
ENSDART00000010813
|
foxa3
|
forkhead box A3 |
chr11_-_11518469 | 26.07 |
ENSDART00000104254
|
krt15
|
keratin 15 |
chr17_-_26867725 | 26.00 |
ENSDART00000153590
|
si:dkey-221l4.10
|
si:dkey-221l4.10 |
chr25_-_169291 | 25.99 |
ENSDART00000128344
|
lipcb
|
lipase, hepatic b |
chr7_+_22657566 | 25.95 |
ENSDART00000141048
|
ponzr5
|
plac8 onzin related protein 5 |
chr1_-_59313465 | 25.92 |
ENSDART00000158067
ENSDART00000159419 |
txndc11
|
thioredoxin domain containing 11 |
chr7_+_66565930 | 25.82 |
ENSDART00000154597
|
tmem176l.3b
|
transmembrane protein 176l.3b |
chr12_+_5708400 | 25.79 |
ENSDART00000017191
|
dlx3b
|
distal-less homeobox 3b |
chr3_-_27647845 | 25.78 |
ENSDART00000151625
|
si:ch211-157c3.4
|
si:ch211-157c3.4 |
chr3_-_50139860 | 25.74 |
ENSDART00000101563
|
btr02
|
bloodthirsty-related gene family, member 2 |
chr16_+_23961276 | 25.74 |
ENSDART00000192754
|
apoeb
|
apolipoprotein Eb |
chr18_+_44703343 | 25.73 |
ENSDART00000131510
|
b3gnt2l
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, like |
chr24_-_40731305 | 25.66 |
ENSDART00000172073
|
CU633479.6
|
|
chr1_+_58922027 | 25.65 |
ENSDART00000159479
|
trip10b
|
thyroid hormone receptor interactor 10b |
chr8_+_2478862 | 25.50 |
ENSDART00000131739
|
si:dkeyp-51b9.3
|
si:dkeyp-51b9.3 |
chr21_-_17956739 | 25.30 |
ENSDART00000148154
|
stx2a
|
syntaxin 2a |
chr7_-_26571994 | 25.22 |
ENSDART00000128801
|
si:dkey-62k3.6
|
si:dkey-62k3.6 |
chr9_+_17309195 | 25.15 |
ENSDART00000048548
|
scel
|
sciellin |
chr19_-_977849 | 25.04 |
ENSDART00000172303
|
CABZ01088282.1
|
|
chr7_+_49654588 | 24.90 |
ENSDART00000025451
ENSDART00000141934 |
rassf7b
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7b |
chr5_-_55981288 | 24.79 |
ENSDART00000146616
|
si:dkey-189h5.6
|
si:dkey-189h5.6 |
chr3_-_39488482 | 24.72 |
ENSDART00000135192
|
zgc:100868
|
zgc:100868 |
chr3_-_39488639 | 24.65 |
ENSDART00000161644
|
zgc:100868
|
zgc:100868 |
chr14_+_14568437 | 24.63 |
ENSDART00000164749
|
pcdh20
|
protocadherin 20 |
chr14_+_15155684 | 24.61 |
ENSDART00000167966
|
zgc:158852
|
zgc:158852 |
chr18_-_7539469 | 24.41 |
ENSDART00000101296
|
si:dkey-30c15.2
|
si:dkey-30c15.2 |
chr4_-_20181964 | 24.32 |
ENSDART00000022539
|
fgl2a
|
fibrinogen-like 2a |
chr23_-_31428763 | 24.11 |
ENSDART00000053545
|
zgc:153284
|
zgc:153284 |
chr18_-_48530221 | 24.02 |
ENSDART00000188134
ENSDART00000142107 |
kcnj1a.2
|
potassium inwardly-rectifying channel, subfamily J, member 1a, tandem duplicate 2 |
chr6_-_7769178 | 24.01 |
ENSDART00000191701
ENSDART00000149823 |
myh9a
|
myosin, heavy chain 9a, non-muscle |
chr11_-_18254 | 24.00 |
ENSDART00000167814
|
prr13
|
proline rich 13 |
chr10_-_2943474 | 23.91 |
ENSDART00000188698
|
oclna
|
occludin a |
chr18_-_29925717 | 23.91 |
ENSDART00000099281
|
mhc2dbb
|
major histocompatibility complex class II DBB gene |
chr21_+_11244068 | 23.84 |
ENSDART00000163432
|
arid6
|
AT-rich interaction domain 6 |
chr22_+_22021936 | 23.71 |
ENSDART00000149586
|
gna15.1
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class), tandem duplicate 1 |
chr16_+_23960744 | 23.41 |
ENSDART00000058965
|
apoeb
|
apolipoprotein Eb |
chr11_-_18449 | 23.19 |
ENSDART00000172050
|
prr13
|
proline rich 13 |
chr2_-_29996036 | 23.14 |
ENSDART00000020792
|
cnpy1
|
canopy1 |
chr2_-_8648440 | 23.07 |
ENSDART00000135743
|
si:ch211-71m22.3
|
si:ch211-71m22.3 |
chr2_-_47620806 | 23.05 |
ENSDART00000038228
|
ap1s3b
|
adaptor-related protein complex 1, sigma 3 subunit, b |
chr17_+_25332711 | 23.02 |
ENSDART00000082319
|
tmem54a
|
transmembrane protein 54a |
chr11_-_669558 | 23.02 |
ENSDART00000173450
|
pparg
|
peroxisome proliferator-activated receptor gamma |
chr22_-_3914162 | 23.00 |
ENSDART00000187174
ENSDART00000190612 ENSDART00000187928 ENSDART00000057224 ENSDART00000184758 |
mhc1uma
|
major histocompatibility complex class I UMA |
chr2_-_58075414 | 22.98 |
ENSDART00000161920
|
nectin4
|
nectin cell adhesion molecule 4 |
chr16_-_46664465 | 22.96 |
ENSDART00000135364
|
tmem176l.4
|
transmembrane protein 176l.4 |
chr10_+_2715548 | 22.93 |
ENSDART00000130793
|
grk5
|
G protein-coupled receptor kinase 5 |
chr20_+_15015557 | 22.93 |
ENSDART00000039345
|
myoc
|
myocilin |
chr4_+_18843015 | 22.89 |
ENSDART00000152086
ENSDART00000066977 ENSDART00000132567 |
bik
|
BCL2 interacting killer |
chr24_-_20444844 | 22.88 |
ENSDART00000048940
|
vill
|
villin-like |
chr17_-_23709347 | 22.88 |
ENSDART00000124661
|
papss2a
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2a |
chr16_+_46725087 | 22.69 |
ENSDART00000008920
|
rab11al
|
RAB11a, member RAS oncogene family, like |
chr7_+_26545911 | 22.66 |
ENSDART00000135313
|
tnk1
|
tyrosine kinase, non-receptor, 1 |
chr11_-_669270 | 22.62 |
ENSDART00000172834
|
pparg
|
peroxisome proliferator-activated receptor gamma |
chr8_-_11170114 | 22.48 |
ENSDART00000133532
|
si:ch211-204d2.4
|
si:ch211-204d2.4 |
chr19_+_10331325 | 22.31 |
ENSDART00000143930
|
tmem238a
|
transmembrane protein 238a |
chr14_-_40821411 | 22.21 |
ENSDART00000166621
|
elf1
|
E74-like ETS transcription factor 1 |
chr22_-_22340688 | 22.12 |
ENSDART00000105597
|
si:ch211-129c21.1
|
si:ch211-129c21.1 |
chr14_+_41345175 | 22.12 |
ENSDART00000086104
|
nox1
|
NADPH oxidase 1 |
chr24_+_31277360 | 22.10 |
ENSDART00000165993
|
f3a
|
coagulation factor IIIa |
chr23_+_31815423 | 22.10 |
ENSDART00000075730
ENSDART00000075726 |
myb
|
v-myb avian myeloblastosis viral oncogene homolog |
chr16_+_40301056 | 22.09 |
ENSDART00000058578
|
rspo3
|
R-spondin 3 |
chr4_-_178510 | 22.00 |
ENSDART00000169805
|
eps8
|
epidermal growth factor receptor pathway substrate 8 |
chr2_+_49457626 | 21.64 |
ENSDART00000129967
|
sh3gl1a
|
SH3-domain GRB2-like 1a |
chr8_+_47099033 | 21.59 |
ENSDART00000142979
|
arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr3_+_36424055 | 21.55 |
ENSDART00000170318
|
si:ch1073-443f11.2
|
si:ch1073-443f11.2 |
chr25_-_32311048 | 21.31 |
ENSDART00000181806
ENSDART00000086334 |
CU372926.1
|
|
chr21_-_25295087 | 21.20 |
ENSDART00000087910
ENSDART00000147860 |
st14b
|
suppression of tumorigenicity 14 (colon carcinoma) b |
chr21_-_11996769 | 21.17 |
ENSDART00000143537
|
zgc:64106
|
zgc:64106 |
chr19_-_34979837 | 20.97 |
ENSDART00000044838
|
ndrg1a
|
N-myc downstream regulated 1a |
chr20_-_17041025 | 20.95 |
ENSDART00000063764
|
si:dkey-5n18.1
|
si:dkey-5n18.1 |
chr1_-_52437056 | 20.94 |
ENSDART00000138337
|
si:ch211-217k17.12
|
si:ch211-217k17.12 |
chr20_-_35578435 | 20.93 |
ENSDART00000142444
|
adgrf6
|
adhesion G protein-coupled receptor F6 |
chr8_-_3312384 | 20.89 |
ENSDART00000035965
|
fut9b
|
fucosyltransferase 9b |
chr16_+_38201840 | 20.85 |
ENSDART00000044971
|
myo1eb
|
myosin IE, b |
chr16_-_31976269 | 20.80 |
ENSDART00000139664
|
styk1
|
serine/threonine/tyrosine kinase 1 |
chr24_-_31904924 | 20.72 |
ENSDART00000156060
ENSDART00000129741 ENSDART00000154276 |
si:ch73-78o10.1
|
si:ch73-78o10.1 |
chr16_+_23947196 | 20.70 |
ENSDART00000103190
ENSDART00000132961 ENSDART00000147690 ENSDART00000142168 |
apoa4b.2
|
apolipoprotein A-IV b, tandem duplicate 2 |
chr6_+_584632 | 20.66 |
ENSDART00000151150
|
zgc:92360
|
zgc:92360 |
chr16_+_35905031 | 20.60 |
ENSDART00000162411
|
sh3d21
|
SH3 domain containing 21 |
chr21_-_27213166 | 20.58 |
ENSDART00000146959
|
mark2a
|
MAP/microtubule affinity-regulating kinase 2a |
chr20_+_26683933 | 20.55 |
ENSDART00000139852
ENSDART00000077751 |
foxq1b
|
forkhead box Q1b |
chr24_-_25244637 | 20.55 |
ENSDART00000153798
|
hhla2b.2
|
HERV-H LTR-associating 2b, tandem duplicate 2 |
chr2_+_4208323 | 20.35 |
ENSDART00000167906
|
gata6
|
GATA binding protein 6 |
chr15_+_36054864 | 20.29 |
ENSDART00000156697
|
col4a3
|
collagen, type IV, alpha 3 |
chr18_-_977075 | 20.26 |
ENSDART00000032392
|
dhdhl
|
dihydrodiol dehydrogenase (dimeric), like |
chr21_-_45882643 | 20.12 |
ENSDART00000168703
|
galnt10
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
chr5_+_29831235 | 20.10 |
ENSDART00000109660
|
f11r.1
|
F11 receptor, tandem duplicate 1 |
chr10_+_29259882 | 20.07 |
ENSDART00000180606
|
sytl2a
|
synaptotagmin-like 2a |
chr4_-_76370630 | 19.92 |
ENSDART00000168831
ENSDART00000174313 |
si:ch73-158p21.3
|
si:ch73-158p21.3 |
chr6_+_36877968 | 19.75 |
ENSDART00000155187
|
traf3ip2l
|
TRAF3 interacting protein 2-like |
chr3_+_32492467 | 19.73 |
ENSDART00000151329
|
trpm4a
|
transient receptor potential cation channel, subfamily M, member 4a |
chr23_-_10175898 | 19.71 |
ENSDART00000146185
|
krt5
|
keratin 5 |
chr17_-_2039511 | 19.71 |
ENSDART00000160223
|
spint1a
|
serine peptidase inhibitor, Kunitz type 1 a |
chr25_+_8356707 | 19.70 |
ENSDART00000153708
|
muc5.1
|
mucin 5.1, oligomeric mucus/gel-forming |
chr24_-_36593876 | 19.70 |
ENSDART00000160901
|
CABZ01055365.1
|
|
chr3_-_8130491 | 19.69 |
ENSDART00000162309
|
si:ch211-51i16.1
|
si:ch211-51i16.1 |
chr7_+_26545502 | 19.66 |
ENSDART00000140528
|
tnk1
|
tyrosine kinase, non-receptor, 1 |
chr13_+_15682803 | 19.61 |
ENSDART00000188063
|
CR931980.1
|
|
chr13_-_36034582 | 19.54 |
ENSDART00000133565
|
si:dkey-157l19.2
|
si:dkey-157l19.2 |
chr23_-_37536127 | 19.51 |
ENSDART00000078253
|
tor1l1
|
torsin family 1 like 1 |
chr10_+_13209580 | 19.45 |
ENSDART00000000887
ENSDART00000136932 |
rassf6
|
Ras association (RalGDS/AF-6) domain family 6 |
chr23_+_17387325 | 19.36 |
ENSDART00000083947
|
ptk6b
|
PTK6 protein tyrosine kinase 6b |
chr4_-_12725513 | 19.30 |
ENSDART00000132286
|
mgst1.2
|
microsomal glutathione S-transferase 1.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.2 | 75.5 | GO:0071831 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) intermediate-density lipoprotein particle clearance(GO:0071831) |
23.2 | 92.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
18.1 | 90.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
16.7 | 50.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
15.5 | 15.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
11.3 | 113.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
10.8 | 32.5 | GO:0002369 | T cell cytokine production(GO:0002369) |
9.7 | 48.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
9.6 | 48.1 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) high-density lipoprotein particle assembly(GO:0034380) |
9.6 | 57.3 | GO:0090134 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
9.3 | 74.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
9.2 | 27.5 | GO:0042730 | fibrinolysis(GO:0042730) |
8.7 | 26.2 | GO:0048785 | hatching gland development(GO:0048785) |
8.6 | 25.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
8.4 | 67.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
7.6 | 22.9 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
7.5 | 45.1 | GO:0003334 | keratinocyte development(GO:0003334) |
7.5 | 44.8 | GO:0045628 | neutrophil apoptotic process(GO:0001781) regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) negative regulation of type 2 immune response(GO:0002829) inflammatory cell apoptotic process(GO:0006925) regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of phospholipase A2 activity(GO:0032429) interleukin-2 production(GO:0032623) regulation of interleukin-2 production(GO:0032663) positive regulation of interleukin-2 production(GO:0032743) myeloid cell apoptotic process(GO:0033028) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) regulation of myeloid cell apoptotic process(GO:0033032) positive regulation of myeloid cell apoptotic process(GO:0033034) T-helper 1 type immune response(GO:0042088) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) T-helper 1 cell differentiation(GO:0045063) positive regulation of T-helper cell differentiation(GO:0045624) regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) positive regulation of fatty acid biosynthetic process(GO:0045723) positive regulation of alpha-beta T cell differentiation(GO:0046638) neutrophil clearance(GO:0097350) negative regulation of phospholipase A2 activity(GO:1900138) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
7.4 | 51.9 | GO:0060855 | venous endothelial cell migration involved in lymph vessel development(GO:0060855) |
7.3 | 21.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
6.4 | 57.2 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
5.7 | 34.0 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
5.5 | 22.1 | GO:0060829 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
5.4 | 16.3 | GO:0046415 | urate catabolic process(GO:0019628) urate metabolic process(GO:0046415) |
5.4 | 5.4 | GO:1900221 | regulation of nitric-oxide synthase activity(GO:0050999) positive regulation of nitric-oxide synthase activity(GO:0051000) beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
5.1 | 51.3 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) |
5.1 | 15.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
5.0 | 30.0 | GO:0048795 | swim bladder morphogenesis(GO:0048795) |
5.0 | 14.9 | GO:1902571 | regulation of serine-type peptidase activity(GO:1902571) |
4.9 | 44.4 | GO:0030104 | water homeostasis(GO:0030104) |
4.9 | 14.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
4.9 | 34.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
4.7 | 23.7 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
4.7 | 14.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
4.7 | 32.7 | GO:0006953 | acute-phase response(GO:0006953) |
4.5 | 212.2 | GO:0043297 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
4.4 | 22.1 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) negative regulation of alkaline phosphatase activity(GO:0010693) |
4.4 | 47.9 | GO:0018120 | peptidyl-arginine ADP-ribosylation(GO:0018120) |
4.3 | 90.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
4.2 | 25.5 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
4.1 | 12.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
4.0 | 11.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
4.0 | 39.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
3.9 | 27.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.9 | 23.3 | GO:0010269 | response to selenium ion(GO:0010269) |
3.9 | 11.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
3.8 | 11.5 | GO:0016045 | detection of biotic stimulus(GO:0009595) detection of bacterium(GO:0016045) detection of other organism(GO:0098543) detection of external biotic stimulus(GO:0098581) |
3.8 | 41.5 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
3.8 | 15.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.7 | 11.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
3.7 | 22.2 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) regulation of neutrophil differentiation(GO:0045658) |
3.7 | 11.1 | GO:0006958 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) complement activation, classical pathway(GO:0006958) |
3.5 | 17.7 | GO:0070292 | N-acylphosphatidylethanolamine metabolic process(GO:0070292) |
3.5 | 13.8 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
3.4 | 13.4 | GO:0009097 | isoleucine metabolic process(GO:0006549) isoleucine biosynthetic process(GO:0009097) |
3.2 | 13.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
3.2 | 16.2 | GO:0010719 | photoreceptor cell morphogenesis(GO:0008594) negative regulation of epithelial to mesenchymal transition(GO:0010719) |
3.1 | 22.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
3.0 | 15.2 | GO:0061011 | hepatic duct development(GO:0061011) |
3.0 | 12.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
3.0 | 18.1 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
2.9 | 46.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
2.9 | 17.4 | GO:0070254 | mucus secretion(GO:0070254) |
2.9 | 5.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
2.9 | 25.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) positive regulation of receptor activity(GO:2000273) |
2.8 | 11.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
2.8 | 8.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
2.8 | 22.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
2.7 | 43.5 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
2.7 | 8.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
2.7 | 13.6 | GO:0033238 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of cellular amine metabolic process(GO:0033238) |
2.7 | 8.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.6 | 7.9 | GO:1903173 | fatty alcohol metabolic process(GO:1903173) |
2.6 | 18.2 | GO:1903963 | icosanoid secretion(GO:0032309) arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
2.6 | 12.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.5 | 7.6 | GO:0032060 | bleb assembly(GO:0032060) slow muscle cell migration(GO:1904969) |
2.5 | 15.0 | GO:0035188 | hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
2.5 | 2.5 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
2.4 | 4.9 | GO:0098586 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) cellular response to virus(GO:0098586) |
2.4 | 14.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
2.4 | 45.4 | GO:0071436 | cellular potassium ion homeostasis(GO:0030007) sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
2.3 | 9.3 | GO:2000392 | lamellipodium morphogenesis(GO:0072673) regulation of lamellipodium morphogenesis(GO:2000392) |
2.3 | 13.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
2.3 | 6.9 | GO:0042543 | protein N-linked glycosylation via arginine(GO:0042543) |
2.3 | 6.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
2.2 | 6.7 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
2.2 | 22.3 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
2.2 | 4.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
2.2 | 21.8 | GO:0051601 | exocyst localization(GO:0051601) |
2.2 | 58.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
2.2 | 32.4 | GO:0031641 | regulation of myelination(GO:0031641) |
2.1 | 15.0 | GO:0042664 | negative regulation of endodermal cell fate specification(GO:0042664) |
2.1 | 35.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
2.1 | 6.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.1 | 6.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
2.1 | 6.2 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
2.1 | 14.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
2.1 | 6.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.0 | 8.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.0 | 42.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
2.0 | 10.1 | GO:0090208 | regulation of triglyceride biosynthetic process(GO:0010866) positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
2.0 | 20.1 | GO:0050892 | intestinal absorption(GO:0050892) |
2.0 | 8.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
2.0 | 14.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.0 | 8.0 | GO:0006598 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
2.0 | 8.0 | GO:0032207 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) |
2.0 | 8.0 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous antigen(GO:0019884) antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.0 | 13.9 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
2.0 | 13.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
2.0 | 47.2 | GO:0051014 | actin filament severing(GO:0051014) |
2.0 | 17.7 | GO:1990402 | embryonic liver development(GO:1990402) |
1.9 | 9.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.9 | 13.5 | GO:0006567 | threonine metabolic process(GO:0006566) threonine catabolic process(GO:0006567) |
1.9 | 32.7 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
1.9 | 13.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.9 | 49.4 | GO:0043588 | skin development(GO:0043588) |
1.9 | 60.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.9 | 16.7 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
1.9 | 220.8 | GO:1990266 | neutrophil migration(GO:1990266) |
1.8 | 16.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.8 | 25.7 | GO:0050870 | positive regulation of homotypic cell-cell adhesion(GO:0034112) positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
1.8 | 5.5 | GO:0052575 | carbohydrate localization(GO:0052575) carbohydrate storage(GO:0052576) |
1.8 | 3.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.8 | 10.8 | GO:0070527 | platelet aggregation(GO:0070527) |
1.8 | 7.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.8 | 8.8 | GO:0048855 | adenohypophysis morphogenesis(GO:0048855) |
1.7 | 5.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.7 | 17.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
1.7 | 41.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.7 | 13.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.7 | 20.7 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
1.7 | 5.1 | GO:0042421 | octopamine biosynthetic process(GO:0006589) dopamine catabolic process(GO:0042420) norepinephrine biosynthetic process(GO:0042421) octopamine metabolic process(GO:0046333) |
1.7 | 18.5 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.7 | 5.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.7 | 11.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
1.7 | 10.1 | GO:0021627 | olfactory nerve development(GO:0021553) olfactory nerve morphogenesis(GO:0021627) olfactory nerve formation(GO:0021628) |
1.7 | 3.4 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
1.7 | 33.4 | GO:0030183 | B cell differentiation(GO:0030183) |
1.7 | 13.3 | GO:2000290 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) regulation of myotome development(GO:2000290) |
1.6 | 3.3 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) |
1.6 | 9.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.6 | 8.1 | GO:0070301 | response to acidic pH(GO:0010447) cellular response to hydrogen peroxide(GO:0070301) |
1.6 | 8.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.6 | 3.2 | GO:0051451 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) myoblast migration(GO:0051451) positive regulation of lamellipodium organization(GO:1902745) |
1.6 | 30.5 | GO:0001843 | neural tube closure(GO:0001843) |
1.6 | 22.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.6 | 35.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.6 | 6.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
1.6 | 4.7 | GO:0070285 | pigment cell development(GO:0070285) |
1.6 | 24.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
1.6 | 4.7 | GO:0042119 | neutrophil activation involved in immune response(GO:0002283) granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
1.5 | 4.6 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.5 | 4.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) protein localization to nuclear envelope(GO:0090435) |
1.5 | 7.6 | GO:0045124 | regulation of bone resorption(GO:0045124) |
1.5 | 15.2 | GO:0010890 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
1.5 | 23.7 | GO:0036065 | fucosylation(GO:0036065) |
1.5 | 5.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.5 | 16.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.5 | 2.9 | GO:0048521 | negative regulation of behavior(GO:0048521) negative regulation of feeding behavior(GO:2000252) |
1.5 | 33.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.4 | 4.3 | GO:0071706 | tumor necrosis factor production(GO:0032640) tumor necrosis factor superfamily cytokine production(GO:0071706) |
1.4 | 56.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.4 | 2.9 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
1.4 | 8.6 | GO:0046218 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.4 | 2.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
1.4 | 8.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.4 | 7.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.4 | 42.1 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
1.4 | 43.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
1.4 | 2.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.4 | 33.8 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
1.3 | 13.5 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
1.3 | 37.3 | GO:2001236 | regulation of extrinsic apoptotic signaling pathway(GO:2001236) |
1.3 | 6.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.3 | 5.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.3 | 10.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.3 | 3.9 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) regulation of lens fiber cell differentiation(GO:1902746) |
1.3 | 7.7 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
1.3 | 7.7 | GO:0097250 | mitochondrial respiratory chain supercomplex assembly(GO:0097250) |
1.3 | 12.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.3 | 6.3 | GO:0001840 | neural plate development(GO:0001840) |
1.3 | 7.5 | GO:1902946 | positive regulation of receptor-mediated endocytosis(GO:0048260) protein localization to early endosome(GO:1902946) |
1.3 | 6.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
1.2 | 8.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.2 | 2.5 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
1.2 | 12.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
1.2 | 19.7 | GO:0006959 | humoral immune response(GO:0006959) |
1.2 | 2.5 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
1.2 | 12.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.2 | 6.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
1.2 | 26.8 | GO:0051923 | sulfation(GO:0051923) |
1.2 | 24.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.2 | 8.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
1.2 | 9.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.2 | 1.2 | GO:0097065 | anterior head development(GO:0097065) |
1.2 | 16.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.2 | 4.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
1.2 | 8.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.2 | 3.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.1 | 8.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 3.4 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
1.1 | 9.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 7.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 4.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 12.2 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.1 | 9.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 9.8 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
1.1 | 18.5 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
1.1 | 20.6 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
1.1 | 3.2 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.1 | 16.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.1 | 109.9 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
1.1 | 3.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 7.4 | GO:0032185 | septin ring organization(GO:0031106) septin cytoskeleton organization(GO:0032185) |
1.0 | 10.3 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
1.0 | 2.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.0 | 6.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.0 | 15.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 5.1 | GO:0003173 | ventriculo bulbo valve development(GO:0003173) |
1.0 | 4.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 11.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.0 | 8.8 | GO:0035141 | medial fin morphogenesis(GO:0035141) |
1.0 | 28.3 | GO:0003094 | glomerular filtration(GO:0003094) |
1.0 | 28.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.0 | 2.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.0 | 2.9 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
1.0 | 48.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.9 | 4.7 | GO:0033273 | response to vitamin(GO:0033273) |
0.9 | 49.3 | GO:0007492 | endoderm development(GO:0007492) |
0.9 | 5.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.9 | 22.7 | GO:1990798 | pancreas regeneration(GO:1990798) |
0.9 | 14.0 | GO:0048382 | mesendoderm development(GO:0048382) |
0.9 | 28.9 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.9 | 7.4 | GO:0071357 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.9 | 6.4 | GO:0061055 | myotome development(GO:0061055) |
0.9 | 3.7 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.9 | 15.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 7.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.9 | 3.5 | GO:0051645 | Golgi localization(GO:0051645) maintenance of centrosome location(GO:0051661) |
0.9 | 3.5 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
0.9 | 2.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.9 | 12.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.9 | 8.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.9 | 17.9 | GO:0060872 | semicircular canal development(GO:0060872) |
0.9 | 5.1 | GO:0060036 | notochord cell vacuolation(GO:0060036) |
0.9 | 135.3 | GO:0006954 | inflammatory response(GO:0006954) |
0.8 | 3.4 | GO:0019068 | virion assembly(GO:0019068) virus maturation(GO:0019075) multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.8 | 5.9 | GO:0072098 | anterior/posterior pattern specification involved in pronephros development(GO:0034672) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.8 | 95.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.8 | 0.8 | GO:0050820 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.8 | 11.6 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.8 | 5.8 | GO:0003188 | heart valve formation(GO:0003188) atrioventricular valve formation(GO:0003190) |
0.8 | 12.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.8 | 4.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 5.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.8 | 2.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) spinal cord association neuron specification(GO:0021519) spinal cord association neuron differentiation(GO:0021527) |
0.8 | 13.0 | GO:0048794 | swim bladder development(GO:0048794) |
0.8 | 14.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.8 | 5.6 | GO:0032475 | otolith formation(GO:0032475) |
0.8 | 4.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.8 | 14.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 89.6 | GO:0008544 | epidermis development(GO:0008544) |
0.8 | 3.2 | GO:2000058 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.8 | 31.6 | GO:0007596 | blood coagulation(GO:0007596) |
0.8 | 14.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 7.1 | GO:0042113 | B cell activation(GO:0042113) |
0.8 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.8 | 12.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.8 | 7.7 | GO:0031272 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 33.1 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) positive regulation of peptidase activity(GO:0010952) |
0.8 | 16.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.8 | 11.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.8 | 8.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.8 | 3.0 | GO:0097037 | heme export(GO:0097037) |
0.8 | 9.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.8 | 2.3 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.8 | 7.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 15.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.7 | 56.5 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.7 | 8.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.7 | 5.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.7 | 17.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.7 | 2.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 5.8 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.7 | 7.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.7 | 5.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.4 | GO:0072526 | pyridine nucleotide catabolic process(GO:0019364) NAD catabolic process(GO:0019677) pyridine-containing compound catabolic process(GO:0072526) |
0.7 | 12.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 10.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 1.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.7 | 41.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.7 | 2.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.7 | 2.7 | GO:0033301 | cell cycle comprising mitosis without cytokinesis(GO:0033301) |
0.7 | 4.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.7 | 11.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 5.9 | GO:0046247 | carotene metabolic process(GO:0016119) carotene catabolic process(GO:0016121) terpene metabolic process(GO:0042214) terpene catabolic process(GO:0046247) |
0.6 | 5.1 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.6 | 6.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.6 | 5.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.6 | 37.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.6 | 14.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.6 | 4.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.6 | 4.4 | GO:0061056 | sclerotome development(GO:0061056) |
0.6 | 9.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.6 | 117.7 | GO:0045087 | innate immune response(GO:0045087) |
0.6 | 2.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.6 | 3.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 7.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.6 | 22.3 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.6 | 31.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.6 | 2.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.6 | 7.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 45.5 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.6 | 4.0 | GO:0042129 | regulation of T cell proliferation(GO:0042129) |
0.6 | 8.6 | GO:0009749 | response to carbohydrate(GO:0009743) response to hexose(GO:0009746) response to glucose(GO:0009749) response to monosaccharide(GO:0034284) |
0.6 | 1.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.6 | 2.3 | GO:0021755 | eurydendroid cell differentiation(GO:0021755) |
0.6 | 9.0 | GO:0042476 | odontogenesis(GO:0042476) |
0.6 | 1.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 12.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.6 | 6.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.6 | 2.2 | GO:1990511 | piRNA biosynthetic process(GO:1990511) |
0.6 | 5.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.6 | 8.9 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.6 | 1.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.5 | 4.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.5 | 60.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.5 | 1.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) |
0.5 | 2.7 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.5 | 1.6 | GO:0048387 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 10.1 | GO:0043534 | blood vessel endothelial cell migration(GO:0043534) |
0.5 | 6.9 | GO:0001841 | neural tube formation(GO:0001841) |
0.5 | 1.6 | GO:0042220 | response to cocaine(GO:0042220) cellular response to alkaloid(GO:0071312) cellular response to cocaine(GO:0071314) |
0.5 | 20.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.5 | 2.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 2.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) formaldehyde catabolic process(GO:0046294) |
0.5 | 93.0 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.5 | 2.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 26.6 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.5 | 5.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.5 | 2.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 17.9 | GO:0044259 | collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.5 | 16.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 2.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.5 | 2.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 2.0 | GO:0071867 | response to monoamine(GO:0071867) response to catecholamine(GO:0071869) response to epinephrine(GO:0071871) |
0.5 | 5.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 2.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 3.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.0 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 5.3 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
0.5 | 3.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 2.4 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.5 | 1.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.5 | 2.8 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 2.3 | GO:0032479 | regulation of type I interferon production(GO:0032479) positive regulation of type I interferon production(GO:0032481) type I interferon production(GO:0032606) |
0.5 | 5.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 1.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 12.8 | GO:0031017 | exocrine pancreas development(GO:0031017) exocrine system development(GO:0035272) |
0.4 | 3.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.4 | 1.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 3.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
0.4 | 2.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 2.8 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.4 | 13.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 4.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 1.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.4 | 3.6 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.4 | 4.7 | GO:0009651 | response to salt stress(GO:0009651) |
0.4 | 3.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.4 | 6.6 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.4 | 3.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 3.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 1.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 5.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.4 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 2.2 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
0.4 | 3.5 | GO:0021654 | rhombomere boundary formation(GO:0021654) |
0.4 | 3.5 | GO:0044206 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) pyrimidine nucleoside salvage(GO:0043097) UMP salvage(GO:0044206) |
0.3 | 3.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 2.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) estrogen metabolic process(GO:0008210) |
0.3 | 3.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 3.8 | GO:0036368 | cone photoresponse recovery(GO:0036368) |
0.3 | 0.3 | GO:0061032 | pericardium development(GO:0060039) visceral serous pericardium development(GO:0061032) |
0.3 | 1.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.3 | GO:0071632 | optomotor response(GO:0071632) |
0.3 | 11.4 | GO:0048916 | posterior lateral line development(GO:0048916) |
0.3 | 1.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.3 | 4.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 1.3 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 5.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 5.2 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.3 | 63.7 | GO:0006955 | immune response(GO:0006955) |
0.3 | 2.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 3.8 | GO:0042541 | hemoglobin metabolic process(GO:0020027) hemoglobin biosynthetic process(GO:0042541) |
0.3 | 2.9 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.3 | 3.8 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.3 | 9.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 4.8 | GO:0048264 | determination of ventral identity(GO:0048264) |
0.3 | 0.6 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) |
0.3 | 17.7 | GO:0031101 | fin regeneration(GO:0031101) |
0.3 | 2.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.3 | 3.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 18.7 | GO:0045765 | regulation of angiogenesis(GO:0045765) |
0.3 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.8 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 18.3 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.3 | 14.4 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.3 | 2.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.3 | 1.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.8 | GO:0006833 | water transport(GO:0006833) |
0.3 | 24.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 5.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.3 | 5.6 | GO:0001878 | response to yeast(GO:0001878) response to fungus(GO:0009620) |
0.3 | 1.3 | GO:0006031 | chitin biosynthetic process(GO:0006031) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.3 | 268.0 | GO:0006508 | proteolysis(GO:0006508) |
0.3 | 5.4 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 2.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.3 | 9.1 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.3 | 1.3 | GO:1904427 | T-tubule organization(GO:0033292) positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of voltage-gated calcium channel activity(GO:1901387) positive regulation of calcium ion transmembrane transport(GO:1904427) |
0.2 | 0.7 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
0.2 | 1.2 | GO:0032196 | transposition(GO:0032196) |
0.2 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 4.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 13.6 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.2 | 1.2 | GO:0048823 | nucleate erythrocyte development(GO:0048823) |
0.2 | 3.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 4.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 11.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 19.4 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.2 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 2.5 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.2 | 4.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 6.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 2.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 11.7 | GO:0055123 | digestive system development(GO:0055123) |
0.2 | 29.9 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.2 | 14.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 1.1 | GO:0097355 | protein localization to heterochromatin(GO:0097355) |
0.2 | 6.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.2 | 1.9 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 1.4 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.2 | GO:0021986 | habenula development(GO:0021986) |
0.2 | 3.4 | GO:0021915 | neural tube development(GO:0021915) |
0.2 | 0.8 | GO:0050435 | beta-amyloid formation(GO:0034205) amyloid precursor protein catabolic process(GO:0042987) beta-amyloid metabolic process(GO:0050435) |
0.2 | 8.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.7 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.2 | 5.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 4.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 2.3 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 4.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 2.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 11.7 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.2 | 2.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 0.9 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.2 | 3.0 | GO:0048538 | thymus development(GO:0048538) |
0.2 | 0.9 | GO:1904036 | negative regulation of epithelial cell apoptotic process(GO:1904036) |
0.2 | 4.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.9 | GO:1901071 | chitin metabolic process(GO:0006030) glucosamine-containing compound metabolic process(GO:1901071) |
0.2 | 1.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 3.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 1.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 3.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 2.3 | GO:0008406 | gonad development(GO:0008406) |
0.2 | 13.5 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 0.8 | GO:0032978 | protein insertion into membrane from inner side(GO:0032978) protein insertion into mitochondrial membrane from inner side(GO:0032979) protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 1.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 5.9 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 2.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 4.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 1.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.5 | GO:0003262 | endocardial progenitor cell migration to the midline involved in heart field formation(GO:0003262) |
0.1 | 2.1 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.5 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 5.9 | GO:0001894 | tissue homeostasis(GO:0001894) |
0.1 | 2.2 | GO:0033334 | fin morphogenesis(GO:0033334) |
0.1 | 1.9 | GO:0030217 | T cell differentiation(GO:0030217) |
0.1 | 0.2 | GO:0034103 | regulation of tissue remodeling(GO:0034103) |
0.1 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 5.8 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.1 | 11.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.4 | GO:0072595 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) maintenance of protein localization in organelle(GO:0072595) |
0.1 | 2.0 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 4.2 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 4.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 2.7 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 4.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.6 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 3.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 1.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 2.0 | GO:0002573 | myeloid leukocyte differentiation(GO:0002573) |
0.1 | 1.7 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 1.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 1.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 2.6 | GO:1903706 | regulation of hemopoiesis(GO:1903706) |
0.1 | 4.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 1.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 1.9 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 1.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 1.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 2.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.6 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 12.9 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.3 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.8 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.0 | 0.8 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 1.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.0 | 0.7 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.8 | GO:0010675 | regulation of cellular carbohydrate metabolic process(GO:0010675) regulation of glucose metabolic process(GO:0010906) |
0.0 | 0.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 2.3 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.2 | 80.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
13.2 | 39.5 | GO:0043218 | compact myelin(GO:0043218) Schmidt-Lanterman incisure(GO:0043220) |
11.9 | 35.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
7.8 | 148.1 | GO:0030057 | desmosome(GO:0030057) |
7.7 | 92.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
5.3 | 15.9 | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane(GO:0098556) |
5.0 | 25.2 | GO:0097433 | dense body(GO:0097433) |
4.5 | 13.4 | GO:0005948 | acetolactate synthase complex(GO:0005948) |
4.4 | 88.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
3.9 | 35.1 | GO:0031526 | brush border membrane(GO:0031526) |
3.7 | 11.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
3.7 | 44.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
3.7 | 22.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
3.6 | 14.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.3 | 409.6 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
3.2 | 16.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
3.0 | 23.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.8 | 56.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
2.8 | 22.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.6 | 12.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
2.3 | 13.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.3 | 16.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.2 | 15.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.2 | 60.5 | GO:0005839 | proteasome core complex(GO:0005839) |
2.1 | 131.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
2.1 | 8.3 | GO:0017177 | glucosidase II complex(GO:0017177) |
2.0 | 10.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
2.0 | 6.0 | GO:0010369 | chromocenter(GO:0010369) |
2.0 | 9.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.0 | 21.7 | GO:0014704 | intercalated disc(GO:0014704) |
1.9 | 3.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
1.9 | 9.3 | GO:0032433 | filopodium tip(GO:0032433) |
1.8 | 25.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.8 | 19.7 | GO:0045095 | keratin filament(GO:0045095) |
1.8 | 7.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.7 | 13.7 | GO:0005614 | interstitial matrix(GO:0005614) |
1.7 | 142.0 | GO:0005581 | collagen trimer(GO:0005581) |
1.6 | 8.1 | GO:0070390 | transcription export complex 2(GO:0070390) |
1.6 | 6.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.5 | 29.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.3 | 32.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.2 | 20.0 | GO:0005869 | dynactin complex(GO:0005869) |
1.2 | 11.2 | GO:0071797 | LUBAC complex(GO:0071797) |
1.2 | 5.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 51.2 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
1.2 | 4.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.1 | 3.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
1.1 | 4.6 | GO:0043073 | germ cell nucleus(GO:0043073) |
1.1 | 4.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.1 | 51.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
1.1 | 103.8 | GO:0005795 | Golgi stack(GO:0005795) |
1.1 | 4.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
1.1 | 60.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.1 | 7.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.0 | 7.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.0 | 128.7 | GO:0016459 | myosin complex(GO:0016459) |
1.0 | 93.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
1.0 | 3.0 | GO:0098536 | deuterosome(GO:0098536) |
1.0 | 31.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 5.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.0 | 22.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
1.0 | 36.0 | GO:0032587 | ruffle membrane(GO:0032587) |
1.0 | 4.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.9 | 4.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 7.5 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 35.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.9 | 2.7 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.9 | 4.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.9 | 19.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.8 | 16.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.8 | 93.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.8 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.8 | 6.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 3.1 | GO:0070209 | ASTRA complex(GO:0070209) |
0.8 | 8.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.8 | 7.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 9.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.8 | 5.4 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.8 | 13.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.7 | 37.9 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 5.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 5.1 | GO:0030892 | nuclear cohesin complex(GO:0000798) mitotic cohesin complex(GO:0030892) nuclear mitotic cohesin complex(GO:0034990) nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 7.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 3.5 | GO:1990923 | PET complex(GO:1990923) |
0.7 | 7.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.7 | 7.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 796.5 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 18.1 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 8.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 12.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 7.4 | GO:0002102 | podosome(GO:0002102) |
0.6 | 118.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.6 | 85.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.6 | 8.8 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.6 | 10.0 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 2.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 4.3 | GO:0032797 | SMN complex(GO:0032797) |
0.5 | 15.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 2.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.5 | 11.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 56.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.5 | 26.1 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 23.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.4 | 2.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 3.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 2.6 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.4 | 1.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 6.1 | GO:0070187 | telosome(GO:0070187) |
0.4 | 1.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 5.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 2.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 10.6 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.4 | 37.1 | GO:0005884 | actin filament(GO:0005884) |
0.4 | 1.4 | GO:0031511 | Mis6-Sim4 complex(GO:0031511) |
0.4 | 7.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.3 | 2.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 12.9 | GO:0016605 | PML body(GO:0016605) |
0.3 | 19.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 19.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 4.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 13.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 17.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 5.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 6.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 12.1 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 3.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 15.4 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 6.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 47.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 2.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 6.7 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 5.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 2.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 10.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.9 | GO:1904423 | dehydrodolichyl diphosphate synthase complex(GO:1904423) |
0.2 | 4.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 26.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 2.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 8.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 1.5 | GO:0030428 | cell septum(GO:0030428) |
0.2 | 17.0 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 2.8 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 1.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 10.4 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 3.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 8.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 3.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.1 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 15.0 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 12.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 3.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 3.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 2.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
0.1 | 7.8 | GO:0005764 | lysosome(GO:0005764) |
0.1 | 2.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 39.1 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.5 | GO:0098844 | dendritic spine head(GO:0044327) postsynaptic endocytic zone(GO:0098843) postsynaptic endocytic zone membrane(GO:0098844) |
0.1 | 2.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 3.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 19.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 5.7 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 3.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.9 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 1.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.2 | 75.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
14.8 | 44.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
10.1 | 30.4 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) |
9.6 | 48.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
9.4 | 47.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
9.3 | 74.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
8.1 | 24.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
7.6 | 22.9 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
7.5 | 44.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
6.5 | 32.7 | GO:0043394 | glycoprotein binding(GO:0001948) proteoglycan binding(GO:0043394) |
6.1 | 24.3 | GO:0004639 | phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
6.0 | 30.0 | GO:0038132 | neuregulin receptor activity(GO:0038131) neuregulin binding(GO:0038132) |
5.8 | 17.3 | GO:0001729 | ceramide kinase activity(GO:0001729) |
5.7 | 56.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
5.1 | 15.3 | GO:0080132 | fatty acid alpha-hydroxylase activity(GO:0080132) |
5.0 | 25.2 | GO:0098973 | structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
5.0 | 64.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
4.8 | 14.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
4.7 | 14.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
4.7 | 14.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
4.6 | 13.8 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
4.5 | 13.4 | GO:0003984 | acetolactate synthase activity(GO:0003984) |
4.4 | 8.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) |
4.4 | 47.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
4.3 | 38.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
4.3 | 90.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
4.1 | 57.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
4.1 | 12.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) |
4.1 | 24.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.8 | 11.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
3.7 | 14.8 | GO:0003796 | lysozyme activity(GO:0003796) |
3.7 | 44.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
3.7 | 18.4 | GO:0098639 | C-X3-C chemokine binding(GO:0019960) protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
3.5 | 17.7 | GO:0039706 | co-receptor binding(GO:0039706) |
3.5 | 13.8 | GO:0017020 | myosin phosphatase regulator activity(GO:0017020) |
3.4 | 13.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
3.4 | 10.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
3.2 | 28.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.1 | 12.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
3.1 | 28.0 | GO:0005113 | patched binding(GO:0005113) |
3.1 | 15.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.0 | 32.9 | GO:0015385 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
3.0 | 23.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
2.9 | 29.1 | GO:0050700 | CARD domain binding(GO:0050700) |
2.9 | 5.8 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
2.8 | 11.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.8 | 8.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.8 | 11.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
2.7 | 16.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.7 | 314.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.7 | 13.5 | GO:0008743 | L-threonine 3-dehydrogenase activity(GO:0008743) |
2.7 | 13.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.6 | 23.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.6 | 39.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.6 | 7.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.6 | 31.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
2.6 | 30.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.5 | 22.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
2.5 | 17.4 | GO:1903924 | estradiol binding(GO:1903924) |
2.5 | 9.9 | GO:0072571 | ADP-D-ribose binding(GO:0072570) mono-ADP-D-ribose binding(GO:0072571) |
2.4 | 19.0 | GO:0008515 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.3 | 7.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.3 | 23.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.3 | 71.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
2.3 | 18.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
2.3 | 280.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.2 | 15.3 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
2.2 | 36.7 | GO:0019894 | kinesin binding(GO:0019894) |
2.1 | 12.9 | GO:0070325 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
2.1 | 19.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.1 | 10.7 | GO:0009374 | biotin binding(GO:0009374) |
2.1 | 14.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.0 | 23.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.9 | 36.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.9 | 7.7 | GO:0008887 | glycerate kinase activity(GO:0008887) |
1.9 | 48.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.8 | 3.7 | GO:0017050 | D-erythro-sphingosine kinase activity(GO:0017050) |
1.8 | 20.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.8 | 34.0 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
1.7 | 7.0 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.7 | 10.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.7 | 6.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.7 | 49.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.7 | 5.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.7 | 10.3 | GO:0017040 | ceramidase activity(GO:0017040) |
1.7 | 389.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.7 | 8.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.7 | 13.6 | GO:0036122 | BMP binding(GO:0036122) |
1.7 | 5.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
1.7 | 6.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.7 | 16.8 | GO:0017091 | AU-rich element binding(GO:0017091) mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.7 | 5.0 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
1.7 | 6.6 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.7 | 5.0 | GO:0046978 | TAP1 binding(GO:0046978) |
1.6 | 6.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.6 | 9.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.6 | 22.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.6 | 7.9 | GO:0051903 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) S-(hydroxymethyl)glutathione dehydrogenase activity(GO:0051903) |
1.6 | 70.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.6 | 15.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.6 | 4.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.5 | 10.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.5 | 7.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.5 | 16.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.5 | 13.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.5 | 16.2 | GO:0031995 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
1.5 | 7.4 | GO:1990518 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity(GO:1990518) |
1.5 | 7.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.5 | 4.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.5 | 4.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.5 | 13.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.5 | 11.7 | GO:0002020 | protease binding(GO:0002020) |
1.4 | 15.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.4 | 14.5 | GO:0016936 | galactoside binding(GO:0016936) |
1.4 | 5.7 | GO:0070052 | collagen V binding(GO:0070052) |
1.4 | 28.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.4 | 15.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.4 | 9.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.4 | 15.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.4 | 5.5 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.4 | 11.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.4 | 12.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
1.4 | 4.1 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
1.4 | 14.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.3 | 7.9 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) glucose binding(GO:0005536) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.3 | 11.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.3 | 32.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.3 | 6.4 | GO:1990756 | protein binding, bridging involved in substrate recognition for ubiquitination(GO:1990756) |
1.3 | 12.8 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 21.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
1.2 | 17.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.2 | 34.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.2 | 11.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.2 | 19.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.2 | 4.9 | GO:0004649 | poly(ADP-ribose) glycohydrolase activity(GO:0004649) |
1.2 | 3.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.2 | 12.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.2 | 8.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.2 | 7.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.2 | 5.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 64.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
1.2 | 16.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.2 | 3.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 9.1 | GO:0072518 | Rho-dependent protein serine/threonine kinase activity(GO:0072518) |
1.1 | 4.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.1 | 5.5 | GO:0004645 | phosphorylase activity(GO:0004645) glycogen phosphorylase activity(GO:0008184) |
1.1 | 4.4 | GO:0005119 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
1.1 | 15.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 10.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.0 | 32.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.0 | 26.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 20.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.0 | 2.1 | GO:0001734 | mRNA (N6-adenosine)-methyltransferase activity(GO:0001734) |
1.0 | 3.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.0 | 17.4 | GO:0015923 | mannosidase activity(GO:0015923) |
1.0 | 5.1 | GO:0008026 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
1.0 | 9.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.0 | 8.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.0 | 4.9 | GO:0016519 | gastric inhibitory peptide receptor activity(GO:0016519) |
1.0 | 15.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 10.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.0 | 48.6 | GO:0043022 | ribosome binding(GO:0043022) |
1.0 | 3.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.9 | 2.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 5.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.9 | 75.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.9 | 1.9 | GO:0052717 | tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.9 | 18.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 5.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.9 | 6.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 99.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.9 | 2.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) IgE receptor activity(GO:0019767) |
0.9 | 7.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.9 | 4.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.9 | 12.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 4.5 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
0.9 | 10.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.9 | 10.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.9 | 11.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.9 | 8.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.9 | 4.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) |
0.9 | 38.6 | GO:0005178 | integrin binding(GO:0005178) |
0.9 | 2.6 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.8 | 27.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 6.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.8 | 18.8 | GO:0005518 | collagen binding(GO:0005518) |
0.8 | 153.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 2.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.8 | 17.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 16.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 14.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 5.6 | GO:0034632 | retinol transporter activity(GO:0034632) |
0.8 | 7.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 7.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.8 | 27.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.8 | 9.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.8 | 17.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.8 | 16.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.8 | 20.5 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 16.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 5.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 91.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 17.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.7 | 20.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.7 | 3.4 | GO:0001735 | prenylcysteine oxidase activity(GO:0001735) |
0.7 | 11.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 4.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 4.6 | GO:0019955 | cytokine binding(GO:0019955) |
0.6 | 2.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 20.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 3.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.6 | 6.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.6 | 2.5 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.6 | 7.4 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 38.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.6 | 3.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 6.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 1.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.6 | 14.4 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 6.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 29.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 10.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 1.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 5.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 92.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.5 | 17.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 5.4 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.5 | 1.6 | GO:0016496 | substance P receptor activity(GO:0016496) |
0.5 | 78.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.5 | 3.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 9.2 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 1.5 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.5 | 17.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 2.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.5 | 7.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 3.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 2.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.5 | 1.5 | GO:0072545 | tyrosine binding(GO:0072545) |
0.5 | 13.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 1.0 | GO:0015369 | calcium:proton antiporter activity(GO:0015369) metal ion:proton antiporter activity(GO:0051139) |
0.5 | 9.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 9.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 13.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 12.6 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.5 | 15.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.5 | 5.1 | GO:0035804 | structural constituent of egg coat(GO:0035804) |
0.4 | 2.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 28.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.4 | 54.1 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.4 | 3.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.3 | GO:0003999 | adenine phosphoribosyltransferase activity(GO:0003999) |
0.4 | 5.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 4.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 5.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 112.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 3.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 1.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 16.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 53.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 3.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 5.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) histone acetyltransferase activity (H3-K23 specific)(GO:0043994) |
0.4 | 7.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 3.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.4 | GO:0001096 | RNA polymerase II basal transcription factor binding(GO:0001091) TFIIF-class transcription factor binding(GO:0001096) |
0.4 | 2.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 7.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 3.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 7.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 7.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 2.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 2.8 | GO:0001217 | bacterial-type RNA polymerase transcription factor activity, sequence-specific DNA binding(GO:0001130) bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding(GO:0001217) |
0.3 | 18.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.3 | 13.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 2.3 | GO:0071916 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) dipeptide transporter activity(GO:0042936) dipeptide transmembrane transporter activity(GO:0071916) |
0.3 | 16.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 21.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 2.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.3 | 10.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.9 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.3 | 0.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 23.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 1.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.3 | 8.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) retinoic acid receptor binding(GO:0042974) |
0.3 | 80.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 5.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.3 | GO:0060182 | apelin receptor activity(GO:0060182) |
0.2 | 20.1 | GO:0042802 | identical protein binding(GO:0042802) |
0.2 | 6.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.2 | 5.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 6.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 6.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 4.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 46.4 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.2 | 2.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 17.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 10.5 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 3.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 1.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 334.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 3.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 6.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 3.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 2.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 3.3 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.6 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.2 | 2.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 3.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0030060 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.2 | 3.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 3.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 11.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 9.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.2 | 1.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 7.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 3.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) |
0.2 | 1.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 2.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 4.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 3.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 2.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 3.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 7.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) NADPH binding(GO:0070402) NADH binding(GO:0070404) |
0.1 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 26.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 97.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.5 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.8 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 3.1 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 7.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 7.8 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 1.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 36.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 13.1 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 18.8 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.6 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 6.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.1 | 5.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 2.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0032977 | membrane insertase activity(GO:0032977) |
0.1 | 44.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 1.7 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.2 | GO:0031151 | histone methyltransferase activity (H3-K79 specific)(GO:0031151) |
0.1 | 3.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 1.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.7 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 5.3 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 5.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 3.4 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.6 | GO:0008233 | peptidase activity(GO:0008233) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 11.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
5.6 | 33.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
5.4 | 139.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
3.5 | 147.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
3.0 | 29.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.3 | 25.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.2 | 58.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.0 | 8.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.7 | 57.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.7 | 15.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.6 | 31.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.6 | 6.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.3 | 22.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.3 | 29.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.3 | 26.5 | PID ENDOTHELIN PATHWAY | Endothelins |
1.3 | 53.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.2 | 10.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.2 | 7.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 46.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.2 | 12.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.2 | 9.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.2 | 13.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.1 | 3.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.1 | 67.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 14.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.1 | 11.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.1 | 8.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.1 | 13.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.1 | 16.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 3.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.0 | 21.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 13.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 37.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.9 | 22.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 5.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 19.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.8 | 4.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 10.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 3.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 2.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 29.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.6 | 23.6 | PID ATR PATHWAY | ATR signaling pathway |
0.6 | 7.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.6 | 6.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 4.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 6.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 27.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 7.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 6.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 7.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 2.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 17.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 6.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 11.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 3.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 4.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 4.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 42.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 40.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 8.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 12.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 8.6 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 3.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 5.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 20.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.2 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.1 | 60.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
7.7 | 68.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
4.8 | 33.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
4.4 | 21.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
3.5 | 28.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.4 | 10.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.9 | 142.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
2.9 | 54.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
2.8 | 39.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.2 | 17.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.8 | 52.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.7 | 24.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.7 | 188.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.6 | 16.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.5 | 25.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.4 | 12.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 28.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.4 | 10.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.3 | 28.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.3 | 16.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.3 | 16.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 7.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.2 | 9.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.1 | 45.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.1 | 10.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.1 | 22.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.1 | 11.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.1 | 14.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.0 | 8.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.0 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.0 | 6.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 26.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.0 | 29.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.0 | 11.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.0 | 11.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.9 | 11.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.9 | 5.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 12.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 15.3 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.9 | 28.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 100.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 25.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 28.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.9 | 20.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 10.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.8 | 5.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 7.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 12.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 9.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 10.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 8.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 18.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.8 | 13.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.7 | 2.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.7 | 11.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 3.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 14.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.6 | 30.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.6 | 6.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 14.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 10.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 3.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.6 | 8.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 25.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.6 | 43.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 3.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 6.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 2.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 43.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 5.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.5 | 5.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.4 | 8.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 4.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 3.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 3.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 2.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 16.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 16.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 14.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 8.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 24.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 8.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 4.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 3.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 2.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 7.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 7.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 5.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 2.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 12.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 10.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 5.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 4.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 6.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |